The store will not work correctly when cookies are disabled.
N-(5-Nitrothiazol-2-yl)-2-(trifluoromethoxy)benzamide
ID: ALA4097372
PubChem CID: 137658973
Max Phase: Preclinical
Molecular Formula: C11H6F3N3O4S
Molecular Weight: 333.25
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ncc([N+](=O)[O-])s1)c1ccccc1OC(F)(F)F
Standard InChI: InChI=1S/C11H6F3N3O4S/c12-11(13,14)21-7-4-2-1-3-6(7)9(18)16-10-15-5-8(22-10)17(19)20/h1-5H,(H,15,16,18)
Standard InChI Key: AOBXGXBHBCYFNI-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
3.4366 -22.4975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4354 -23.3170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1435 -23.7260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8531 -23.3165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8503 -22.4939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1417 -22.0886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5565 -22.0826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2657 -22.4886 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5534 -21.2654 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9719 -22.0773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7190 -22.4057 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2635 -21.7963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8522 -21.0901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0536 -21.2631 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.1836 -20.3388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7007 -19.6795 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.9960 -20.2502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1392 -21.2714 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4303 -20.8650 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4279 -20.0478 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.7238 -21.2757 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2.7198 -20.4545 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 10 1 0
15 16 2 0
15 17 1 0
13 15 1 0
6 18 1 0
18 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
M CHG 2 15 1 17 -1
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.25 | Molecular Weight (Monoisotopic): 333.0031 | AlogP: 3.20 | #Rotatable Bonds: 4 |
Polar Surface Area: 94.36 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.66 | CX Basic pKa: ┄ | CX LogP: 3.95 | CX LogD: 3.95 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.68 | Np Likeness Score: -2.18 |
References
1. Buchieri MV, Cimino M, Rebollo-Ramirez S, Beauvineau C, Cascioferro A, Favre-Rochex S, Helynck O, Naud-Martin D, Larrouy-Maumus G, Munier-Lehmann H, Gicquel B.. (2017) Nitazoxanide Analogs Require Nitroreduction for Antimicrobial Activity in Mycobacterium smegmatis., 60 (17): [PMID:28846409] [10.1021/acs.jmedchem.7b00726] |